In a report released today, Alexander Nowak from Craig-Hallum initiated coverage with a Buy rating on ProSomnus (OSA – Research Report) and a price target of $10.00. The company’s shares closed last Friday at $5.21.
According to TipRanks, Nowak is an analyst with an average return of -7.6% and a 36.46% success rate. Nowak covers the Healthcare sector, focusing on stocks such as CVRx, Miromatrix Medical, and Stereotaxis.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for ProSomnus with a $10.00 average price target.
See the top stocks recommended by analysts >>
OSA market cap is currently $83.61M and has a P/E ratio of -187.41.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Lakeshore Acquisition I Corp is a blank check company. Its objective is to acquire, through a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities.
Read More on OSA:
- ProSomnus Reports Fourth Quarter and Fiscal Year 2022 Financial Results
- ProSomnus receives patent allowance covering automated manufacturing process
- ProSomnus® Receives Patent Allowance Covering Automated Manufacturing Process for Company’s Novel Precision Sleep Apnea Medical Devices
- ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023
- ProSomnus announces acceptance of abstract at ERS and ESRS Conference
